GO:0061364 apoptotic process involved in luteolysis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061364 apoptotic process involved in luteolysis describes the programmed cell death that dismantles the corpus luteum after its functional lifespan ends.
• Luteolysis is a two-stage event: functional luteolysis (loss of progesterone output) precedes structural luteolysis (apoptotic tissue involution).
• The intrinsic mitochondrial apoptotic pathway, driven by BAX, BAK, CASP3 and CASP9, is the principal executioner of luteal cell death.
• Endoplasmic reticulum stress and its downstream apoptotic signaling contribute to corpus luteum regression in vivo.
• Matrix metalloproteinases remodel the extracellular matrix during structural luteolysis and are tightly linked to apoptotic cell loss.
• Species-specific endocrine triggers (PGF2A in ruminants, estradiol/PGF2A interactions in pigs and dogs) control when this apoptotic program is activated.
Description
The corpus luteum is a transient endocrine gland that forms from the ruptured ovarian follicle and secretes progesterone to support early pregnancy. When pregnancy does not occur, or when luteal support is no longer required, the corpus luteum must be eliminated in a controlled manner; this regression process is called luteolysis. GO:0061364, apoptotic process involved in luteolysis, captures the specific programmed cell death component of that regression, distinguishing it from the broader, multi-process phenomenon of luteolysis itself. Because luteolysis determines the length of the ovarian cycle and the timing of subsequent ovulations, the apoptotic events it contains are of central interest to reproductive biologists, veterinarians and clinicians studying fertility. Mechanistically, luteal regression is classically divided into functional luteolysis, in which progesterone secretion falls, and structural luteolysis, in which luteal cells are physically removed by apoptosis and tissue remodeling. The apoptotic process covered by GO:0061364 is the structural arm: it involves mitochondrial outer membrane permeabilization, caspase activation and phagocytic clearance of dying luteal cells. Endocrine signals such as prostaglandin F2 alpha (PGF2A) initiate this cascade in ruminants, while in pigs and dogs additional luteotrophic and luteolytic inputs modulate the timing and intensity of cell death. For researchers, GO:0061364 provides a precise annotation target when studying genes whose products execute or regulate luteal apoptosis. It allows RNA-seq, proteomic and CRISPR perturbation data to be mapped onto a defined biological process rather than a vague notion of ovarian regression. This article summarizes the QuickGO definition, the molecular stages of the process, the genes repeatedly implicated in it, and the experimental models and methods used to interrogate it.
apoptotic process involved in luteolysis At A Glance
| GO ID | GO:0061364 |
|---|---|
| GO term | apoptotic process involved in luteolysis |
| Ontology | biological_process |
| Synonym | apoptosis involved in luteolysis; structural luteolysis |
| Definition | The apoptotic process that contributes to luteolysis. |
| Major function | Programmed elimination of luteal cells during corpus luteum regression |
| Related process | Luteolysis; functional luteolysis precedes structural luteolysis |
| Key executioners | BAX, BAK, CASP3, CASP9, CASP8 |
| Key regulators | PGF2A signaling, ER stress, matrix metalloproteinases |
| Physiological context | Ovarian cycle, pregnancy maintenance, fertility |
| Taxonomic scope | Metazoan ovaries, especially ruminants, pigs, dogs, rodents |
What Is GO:0061364?
According to QuickGO, GO:0061364 (apoptotic process involved in luteolysis) is defined as the apoptotic process that contributes to luteolysis. In other words, it is not luteolysis as a whole but specifically the programmed cell death subprogram that helps break down the corpus luteum. Its synonym structural luteolysis reflects the fact that apoptotic cell loss is the structural, tissue-remodeling phase of luteal regression, as opposed to the earlier functional loss of progesterone secretion.
Why Is apoptotic process involved in luteolysis Important in Cell Biology?
GO:0061364 matters because the timing of luteal apoptosis directly controls cycle length, the interval to the next ovulation and the ability to maintain early pregnancy. When luteal apoptosis is premature, progesterone support is lost too early and pregnancy fails; when it is delayed, the corpus luteum persists and disrupts normal cyclicity. Because the process is executed by conserved apoptotic machinery, it also serves as a tractable in vivo model of physiological apoptosis, informing both reproductive medicine and general cell death biology.
• Determines the length of the luteal phase and the timing of the next ovulation.
• Controls progesterone withdrawal, which is required for menstruation and parturition in many species.
• Premature luteal apoptosis is associated with reduced fertility and early pregnancy loss.
• Persistent corpora lutea, reflecting failed apoptosis, disrupt ovarian cyclicity.
• Provides an in vivo model of physiological apoptosis driven by mitochondrial and ER stress pathways.
• Links endocrine signaling (PGF2A, estradiol) to cell death execution.
• Involves matrix metalloproteinases, connecting apoptosis to extracellular matrix remodeling.
• Relevant to veterinary reproduction in cattle, pigs and dogs.
• Offers targets for fertility regulation and luteal support strategies.
• Serves as a benchmark process for CRISPR-based functional studies of ovarian genes.
What Happens During apoptotic process involved in luteolysis?
Initiation by luteolytic signals
In simple terms: A hormone signal tells the corpus luteum that its time is up.
In ruminants, prostaglandin F2 alpha (PGF2A) released from the uterus is the principal luteolytic signal that initiates corpus luteum regression. In pigs, luteolysis is regulated by a complex interplay of luteotrophic and luteolytic factors during the estrous cycle and pregnancy. In dogs, endocrine and morpho-functional regulation of luteal lifespan involves species-specific mechanisms that determine when apoptotic regression begins. These endocrine inputs set the stage for the apoptotic process annotated as GO:0061364.
Functional luteolysis precedes structural apoptosis
In simple terms: First the gland stops making progesterone, then its cells die.
Luteolysis is classically divided into functional luteolysis, characterized by a rapid decline in progesterone secretion, and structural luteolysis, in which luteal cells are eliminated. The apoptotic process of GO:0061364 corresponds primarily to the structural phase, although apoptotic signaling can begin during functional regression. This temporal separation is important because progesterone withdrawal triggers downstream events, including menstrual shedding and parturition, before tissue involution is complete.
Mitochondrial (intrinsic) apoptotic pathway activation
In simple terms: The cell's powerhouses release death signals that activate caspases.
The intrinsic mitochondrial pathway is a major executor of luteal apoptosis. In the bovine corpus luteum after induced luteolysis, expression of apoptotic factors including BAX and caspases changes in a coordinated manner consistent with mitochondrial pathway activation. The corpus luteum has been described as an ovarian structure with maternal instincts and suicidal tendencies, reflecting its built-in apoptotic program. BAX and BAK permeabilize the mitochondrial outer membrane, releasing cytochrome c and activating CASP9 and downstream CASP3.
Endoplasmic reticulum stress contribution
In simple terms: Cellular stress in the protein-folding factory also pushes luteal cells toward death.
Endoplasmic reticulum stress-mediated apoptotic pathways are involved in corpus luteum regression in rats, indicating that ER stress signaling converges on the same apoptotic execution machinery. This provides a second intrinsic trigger alongside mitochondrial pathway activation, and it may amplify cell death when luteal cells experience metabolic or oxidative stress during regression.
Extracellular matrix remodeling and tissue involution
In simple terms: Enzymes chew up the scaffold so dying cells can be cleared and the gland shrinks.
Matrix metalloproteinases play significant roles in the pathophysiology of the ovary and uterus, including the structural remodeling that accompanies luteal regression. As apoptotic luteal cells are cleared, matrix metalloproteinase activity degrades extracellular matrix components, allowing the corpus luteum to shrink and be replaced by scar tissue. This coupling of apoptosis to matrix remodeling is why GO:0061364 is synonymous with structural luteolysis.
Clearance of apoptotic luteal cells
In simple terms: Dying cells are removed so the gland can fully regress.
Apoptotic luteal cells are recognized and phagocytosed, completing the structural involution of the corpus luteum. Efficient clearance prevents release of intracellular contents that could provoke inflammation, and it is required for the ovary to return to a state permissive for a new follicular wave. The entire sequence, from endocrine trigger to clearance, constitutes the apoptotic process involved in luteolysis.
Key Genes Involved in GO:0061364 apoptotic process involved in luteolysis
The following genes and proteins have been repeatedly implicated in the apoptotic process involved in luteolysis, based on the verified literature on corpus luteum regression.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BAX | Pro-apoptotic BCL2 family effector; permeabilizes mitochondria | Expression changes in bovine corpus luteum after induced luteolysis |
| BAK | Pro-apoptotic BCL2 family effector; cooperates with BAX | Core mitochondrial apoptosis execution in luteal cells |
| CASP3 | Executioner caspase; cleaves key cellular substrates | Marker of luteal apoptosis in bovine and rat models |
| CASP9 | Initiator caspase of the intrinsic pathway | Activated downstream of mitochondrial permeabilization |
| CASP8 | Initiator caspase of the extrinsic pathway | Potential extrinsic contribution to luteal apoptosis |
| BCL2 | Anti-apoptotic BCL2 family protein | Shifts in BCL2/BAX ratio accompany luteolysis |
| TP53 | Stress-responsive transcription factor | Can sensitize luteal cells to apoptosis under stress |
| MMP2 | Matrix metalloproteinase; degrades type IV collagen | Extracellular matrix remodeling during structural luteolysis |
| MMP9 | Matrix metalloproteinase; degrades denatured collagen | Linked to ovarian tissue remodeling and luteal regression |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 | Prostaglandin synthesis relevant to luteolytic signaling |
| PTGFR | PGF2A receptor | Mediates luteolytic PGF2A action in ruminants |
| ESR1 | Estrogen receptor alpha | Estradiol signaling influences luteal lifespan in pigs and dogs |
| ESR2 | Estrogen receptor beta | Modulates luteal gene expression during regression |
| LHCGR | Luteinizing hormone/chorionic gonadotropin receptor | Luteotrophic support opposes luteolysis |
| STAR | Steroidogenic acute regulatory protein | Progesterone synthesis declines during functional luteolysis |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | Steroidogenic capacity lost during luteal regression |
| HSD3B1 | 3-beta-hydroxysteroid dehydrogenase | Progesterone production marker during luteal lifespan |
| VEGFA | Vascular endothelial growth factor A | Angiogenic remodeling during luteal regression |
How Is apoptotic process involved in luteolysis Regulated?
The apoptotic process involved in luteolysis is regulated at multiple levels. Endocrine control is dominant: PGF2A in ruminants and complex luteotrophic/luteolytic interactions in pigs and dogs determine when the program is switched on. Luteinizing hormone and chorionic gonadotropin provide luteotrophic support that suppresses apoptosis while pregnancy is maintained. Intracellularly, the balance between pro-apoptotic (BAX, BAK) and anti-apoptotic (BCL2) BCL2 family proteins sets the threshold for mitochondrial outer membrane permeabilization. Endoplasmic reticulum stress signaling can lower this threshold and amplify caspase activation during regression. Finally, matrix metalloproteinase activity is regulated in concert with apoptosis to ensure coordinated tissue remodeling rather than isolated cell death.
apoptotic process involved in luteolysis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BAX | Premature luteal apoptosis and early pregnancy loss | Bax knockout or point-mutation luteal cell models |
| CASP3 | Defective execution of luteal apoptosis | Casp3 knockout or knock-in reporter models |
| MMP2 | Abnormal ovarian extracellular matrix remodeling | Mmp2 knockout or overexpression luteal models |
| PTGFR | Impaired PGF2A-driven luteolysis in ruminants | Ptgfr knockout or point-mutation models |
| ESR1 | Altered luteal lifespan in pigs and dogs | Esr1 knockout or knock-in models |
Reduced fertility and anovulation in dairy cattle
Mechanisms underlying reduced fertility in anovular dairy cows include disrupted luteal function and altered timing of luteolysis, which affects progesterone support and pregnancy establishment. Because GO:0061364 governs the structural removal of the corpus luteum, perturbations in its timing can contribute to infertility in high-producing dairy herds.
Luteal phase defects and early pregnancy loss
Luteal-phase endocrinology determines whether the endometrium is adequately primed for implantation. If luteal apoptosis occurs prematurely, progesterone withdrawal can cause early pregnancy loss, whereas delayed apoptosis can disrupt cycle regularity. Understanding GO:0061364 therefore informs clinical management of luteal phase deficiency.
Persistent corpus luteum and ovarian cycle disorders
In dogs and pigs, species-specific endocrine and morpho-functional regulation controls luteal lifespan. Failure of the apoptotic program can lead to persistent corpora lutea, which interfere with normal cyclicity and fertility. These conditions highlight the clinical importance of the apoptotic process involved in luteolysis.
Ovarian tissue remodeling and matrix pathology
Matrix metalloproteinases are significant in the pathophysiology of the ovary and uterus, and their dysregulation during luteal regression can affect tissue architecture. Abnormal extracellular matrix remodeling during structural luteolysis may contribute to ovarian pathology and impaired recovery after each cycle.
From apoptotic process involved in luteolysis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is BAX required for luteal apoptosis? | BAX knockout luteal cell line or animal model |
| Does a specific caspase cleavage site drive regression? | Point-mutation knock-in of caspase substrate |
| How does ER stress amplify luteal apoptosis? | Overexpression of ER stress effectors in luteal cells |
| What is the role of PGF2A receptor signaling? | PTGFR knockout or tagged knock-in reporter |
| How do matrix metalloproteinases coordinate involution? | MMP2/MMP9 knockout or overexpression models |
| Which genes are essential for structural luteolysis? | CRISPR library screening in luteal cell models |
How to Study the apoptotic process involved in luteolysis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes during luteal regression | Identifying apoptotic genes altered after induced luteolysis |
| Western blot | Protein levels of BAX, BCL2, caspases | Confirming mitochondrial pathway activation |
| Caspase activity assay | Enzymatic activity of CASP3/CASP9 | Quantifying apoptotic execution |
| TUNEL staining | DNA fragmentation in situ | Localizing apoptotic luteal cells |
| Progesterone assay | Functional luteolysis timing | Defining the window for structural apoptosis |
| Zymography | Matrix metalloproteinase activity | Assessing extracellular matrix remodeling |
| ER stress marker analysis | ER stress pathway activation | Linking ER stress to luteal apoptosis |
| CRISPR library screening | Gene essentiality for luteal apoptosis | Discovering novel regulators of GO:0061364 |
Transcriptomic profiling of luteal regression
RNA-seq of corpora lutea collected before and after induced luteolysis can identify genes whose expression changes in concert with GO:0061364. In bovine models, induced luteolysis produces measurable shifts in apoptotic factor transcripts, providing a template for time-course designs. Comparative transcriptomics across species can reveal conserved versus species-specific regulators.
Protein-level analysis of apoptotic executioners
Western blotting and activity assays for CASP3 and CASP9, together with BAX/BCL2 ratio measurements, are standard readouts of luteal apoptosis. Because ER stress contributes to regression, markers such as ER stress-responsive proteins can be monitored in parallel. Proteomic approaches can capture matrix metalloproteinase changes associated with structural luteolysis.
Histological and imaging assessment of structural luteolysis
TUNEL staining and cleaved caspase immunohistochemistry localize apoptotic cells within the regressing corpus luteum. Imaging of luteal size and vascularity tracks the structural involution that defines structural luteolysis. These methods connect molecular apoptotic markers to tissue-level outcomes.
Endocrine and functional luteolysis monitoring
Serial progesterone measurements define functional luteolysis and establish the temporal window in which apoptotic events occur. In ruminants, PGF2A administration is used experimentally to synchronize luteolysis and study the subsequent apoptotic cascade. In pigs and dogs, species-specific endocrine profiles must be considered when designing such experiments.
How CRISPR Can Be Used to Study GO:0061364 apoptotic process involved in luteolysis
Knockout
CRISPR knockout of candidate genes such as BAX, CASP3 or MMP2 in luteal cell models can test whether they are required for the apoptotic process involved in luteolysis. Loss-of-function models allow researchers to measure changes in caspase activation, DNA fragmentation and progesterone output. Knockout studies in vivo or ex vivo can also reveal compensatory pathways that mask single-gene loss.
Point Mutation
Point-mutation knock-in can be used to disable specific phosphorylation sites or caspase cleavage sites in apoptotic regulators, testing their causal contribution to luteal regression. Such models are valuable when complete knockout causes developmental lethality or confounding phenotypes. They allow fine mapping of signaling events downstream of PGF2A and ER stress.
Knock-in
Tagged knock-in of apoptotic effectors with fluorescent or epitope tags enables live tracking of their localization and turnover during luteolysis. Reporter knock-in of caspase substrates can provide sensitive readouts of apoptotic activity in luteal tissue. These models bridge molecular mechanism and tissue-level regression.
Overexpression
Overexpression of pro-apoptotic factors such as BAX or ER stress effectors in luteal cells can test whether their elevation is sufficient to trigger premature regression. Conversely, overexpression of anti-apoptotic BCL2 can test whether apoptosis is required for structural luteolysis. Overexpression models are also useful for studying matrix metalloproteinase-driven remodeling.
How EDITGENE Supports apoptotic process involved in luteolysis Research
Researchers studying apoptotic process involved in luteolysis-related genes often need to determine whether a candidate gene is causally involved in luteal cell death or is merely a bystander of regression. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation in this reproductive biology context.
Contact EDITGENE today to design your custom CRISPR model for apoptotic process involved in luteolysis research.
Frequently Asked Questions About apoptotic process involved in luteolysis
What is GO:0061364 apoptotic process involved in luteolysis?
GO:0061364 is a Gene Ontology biological process term defined as the apoptotic process that contributes to luteolysis, also known as structural luteolysis.
What is the difference between luteolysis and apoptotic process involved in luteolysis?
Luteolysis is the broader regression of the corpus luteum, including functional loss of progesterone secretion, whereas GO:0061364 specifically covers the apoptotic cell death that drives structural involution.
What genes are involved in apoptotic process involved in luteolysis?
Key genes include BAX, BAK, CASP3, CASP9, BCL2, MMP2, MMP9 and PTGFR, based on studies of corpus luteum regression.
Which pathway mediates luteal apoptosis?
The intrinsic mitochondrial pathway, involving BAX/BAK, cytochrome c release and caspase activation, is a principal mediator, with additional contribution from endoplasmic reticulum stress.
Why is luteal apoptosis important for fertility?
Timely luteal apoptosis controls cycle length and progesterone withdrawal; premature or delayed apoptosis can impair fertility and pregnancy maintenance.
What triggers luteolysis in ruminants?
Prostaglandin F2 alpha (PGF2A) released from the uterus is the principal luteolytic trigger in ruminants.
How is luteolysis regulated in pigs?
Porcine corpus luteum regulation during pregnancy involves complex luteotrophic and luteolytic interactions that determine luteal lifespan.
What role do matrix metalloproteinases play in luteolysis?
Matrix metalloproteinases remodel the extracellular matrix during structural luteolysis, complementing apoptotic cell loss.
Can CRISPR be used to study luteal apoptosis genes?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate genes in luteal cell systems.
What methods are used to study apoptotic process involved in luteolysis?
Common methods include RNA-seq, western blotting, caspase activity assays, TUNEL staining, progesterone assays and zymography.
Conclusion
GO:0061364 apoptotic process involved in luteolysis defines the programmed cell death program that structurally dismantles the corpus luteum after its functional lifespan ends. It is executed primarily through the mitochondrial apoptotic pathway, with contributions from endoplasmic reticulum stress and matrix metalloproteinase-mediated remodeling. Because its timing determines cycle length and pregnancy maintenance, it is a central process in reproductive biology and veterinary medicine. Researchers can now interrogate this process with CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomic, proteomic and imaging readouts. Such approaches promise to clarify which genes are truly causal for luteal apoptosis and how their dysregulation contributes to infertility and ovarian disorders.
References
- 1. Messinis IE et al.. 2009. Luteal-phase endocrinology.. Reprod Biomed Online 19 Suppl 4:4314 PMID: 20034416
- 2. Yang Y et al.. 2015. Endoplasmic reticulum stress-mediated apoptotic pathway is involved in corpus luteum regression in rats.. Reprod Sci 22(5):572-84 PMID: 25332219
- 3. Endo T et al.. 2006. Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.. Reprod Med Biol 5(4):235-243 PMID: 29699252
- 4. Santos JE et al.. 2016. Mechanisms underlying reduced fertility in anovular dairy cows.. Theriogenology 86(1):254-62 PMID: 27160451
- 5. Kowalewski MP. 2023. Advances in understanding canine pregnancy: Endocrine and morpho-functional regulation.. Reprod Domest Anim 58 Suppl 2:163-175 PMID: 37724655
- 6. Ziecik AJ et al.. 2018. Regulation of the porcine corpus luteum during pregnancy.. Reproduction 156(3):R57-R67 PMID: 29794023
- 7. Kliem H et al.. 2009. Regulatory changes of apoptotic factors in the bovine corpus luteum after induced luteolysis.. Mol Reprod Dev 76(3):220-30 PMID: 18563705
- 8. Davis JS et al.. 2002. The corpus luteum: an ovarian structure with maternal instincts and suicidal tendencies.. Front Biosci 7:d1949-78 PMID: 12161347
